Cited by 1,518Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and MetabolismNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, Jeffrey D., Patel, Sarjubhai, Regan, Melissa R., Haenggeli, Christine, Huang, Yanhua H., Bergles, Dwight E., Jin, Lin, Dykes Hoberg, Margaret, Vidensky, Svetlana, Chung, Dorothy S., Toan, Shuy Vang, Bruijn, Lucie I., Su, Zao-zhong, Gupta, Pankaj, Fisher, Paul B.·2005·Nature

DOI 10.1038/nature03180

Open this paper in CoChat — free account

Abstract

Glutamate is the principal excitatory neurotransmitter in the nervous system. Inactivation of synaptic glutamate is handled by the glutamate transporter GLT1 (also known as EAAT2; refs 1, 2), the physiologically dominant astroglial protein. In spite of its critical importance in normal and abnormal synaptic activity, no practical pharmaceutical can positively modulate this protein. Animal studies show that the protein is important for normal excitatory synaptic transmission, while its dysfunction is implicated in acute and chronic neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, brain tumours and epilepsy. Using a blinded screen of 1,040 FDA-approved drugs and nutritionals, we discovered that many beta-lactam antibiotics are potent stimulators of GLT1 expression. Furthermore, this action appears to be mediated through increased transcription of the GLT1 gene. beta-Lactams and various semi-synthetic derivatives are potent antibiotics that act to inhibit bacterial synthetic pathways. When delivered to animals, the beta-lactam ceftriaxone increased both brain expression of GLT1 and its biochemical and functional activity. Glutamate transporters are important in preventing glutamate neurotoxicity. Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity. When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival. Thus these studies provide a class of potential neurotherapeutics that act to modulate the expression of glutamate neurotransmitter transporters via gene activation.

Integrity signals

Registry

Crossref · 10.1038/nature03180

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
Glutamate uptake
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citation
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citation
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,197
Self-citation
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
Howland, D., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B. B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 890
Self-citation
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Self-citation
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Self-citation

Flagged first, then by citations

Show all 27 references

Sorted by citations

Items 301–400 of 1,000

Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective
Malaspina, A., Puentes, F., & Amor, S. (2014) · International Immunology · doi:10.1093/intimm/dxu099 · Cited by 92
Peripheral nerve injury produces a sustained shift in the balance between glutamate release and uptake in the dorsal horn of the spinal cord
Inquimbert, P., Bartels, K., Babaniyi, O., Barrett, L. B., Tegeder, I., & Scholz, J. (2012) · Pain · doi:10.1016/j.pain.2012.08.011 · Cited by 92
Bibliometric and Visual Analysis of Research on the Links Between the Gut Microbiota and Depression From 1999 to 2019
Zhu, X., Hu, J., Deng, S., Tan, Y., Qiu, C., Zhang, M., Ni, X., Lu, H., Wang, Z., Li, L., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587670 · Cited by 92
The beta-lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti-excitotoxicity and anti-inflammation response in a rat model of traumatic brain injury
Wei, J., Pan, X.-D., Pei, Z., Wang, W., Qiu, W., Shi, Z., & Xiao, G. (2012) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31825133c0 · Cited by 91
β-synuclein modulates α-synuclein neurotoxicity by reducing α-synuclein protein expression
Fan, Y., Limprasert, P., Murray, I. V. J., Smith, A. C., Lee, V. M. ‐., Trojanowski, J. Q., Sopher, B. L., & Spada, A. R. L. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl242 · Cited by 90
Amyotrophic lateral sclerosis: update and new developments
Perry, J. J. P., Pratt, A. J., & Getzoff (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s19803 · Cited by 94
Lyme Borreliosis in Human Patients in Florida and Georgia, USA
Clark, K. L., Leydet, B. F., & Hartman, S. (2013) · International Journal of Medical Sciences · doi:10.7150/ijms.6273 · Cited by 89
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88
Glial Glutamine Homeostasis in Health and Disease
Andersen, J. V., & Schousboe, A. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03771-1 · Cited by 92
Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities
Jensen, A. A., Fahlke, C. M., Bjørn-Yoshimoto, W. E., & Bunch, L. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.008 · Cited by 88
Targeting glial physiology and glutamate cycling in the treatment of depression
Valentine, G. W., & Sanacora, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.04.008 · Cited by 87
Differential effects of cocaine access and withdrawal on glutamate type 1 transporter expression in rat nucleus accumbens core and shell
Fischer, K. D., Houston, A. C. W., & Rebec, G. V. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.049 · Cited by 90
Enhancing Glutamate Transport: Mechanism of Action of Parawixin1, a Neuroprotective Compound from Parawixia bistriata Spider Venom
Fontana, A. C. K., Beleboni, R. O., Wojewodzic, M. W., dos Santos, W. F., Coutinho‐Netto, J., Grutle, N. J., Watts, S. D., Danbolt, N. C., & Amara, S. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.037127 · Cited by 88
Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model
Chotibut, T., Davis, R. W., Arnold, J. C., Frenchek, Z., Gurwara, S., Bondada, V., Geddes, J. W., & Salvatore, M. F. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8598-0 · Cited by 86
Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats
Sari, Y., & Sreemantula, S. N. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.10.007 · Cited by 86
Glutamate transporters
Benarroch, E. E. (2010) · Neurology · doi:10.1212/wnl.0b013e3181cc89e3 · Cited by 86
FDA-Approved Drugs that Protect Mammalian Neurons from Glucose Toxicity Slow Aging Dependent on Cbp and Protect Against Proteotoxicity
Lublin, A. L., Isoda, F., Patel, H., Yen, K., Nguyen, L., Hajje, D., Schwartz, M., & Mobbs, C. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027762 · Cited by 88
Synaptic dysfunction and altered excitability in C9ORF72 ALS/FTD
Starr, A., & Sattler, R. (2018) · Brain Research · doi:10.1016/j.brainres.2018.02.011 · Cited by 78
The neurobiology of amyotrophic lateral sclerosis
Bento‐Abreu, A., Damme, P. V., Bosch, L. V. D., & Robberecht, W. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07260.x · Cited by 89
Glutamate transporters in brain ischemia: to modulate or not?
Krzyżanowska, W., Pomierny, B., Filip, M., & Pera, J. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.1 · Cited by 86
Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm
Abulseoud, O. A., Miller, J. D., Wu, J., Choi, D., & Holschneider, D. P. (2012) · Brain Research · doi:10.1016/j.brainres.2012.03.045 · Cited by 87
Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking
Sondheimer, I., & Knackstedt, L. A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.07.041 · Cited by 89
Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice
Gourley, S. L., Espitia, J. W., Sanacora, G., & Taylor, J. R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2403-4 · Cited by 89
A β-Lactam Antibiotic Dampens Excitotoxic Inflammatory CNS Damage in a Mouse Model of Multiple Sclerosis
Melzer, N., Meuth, S. G., Torres‐Salazar, D., Bittner, S., Zozulya, A. L., Weidenfeller, C., Kotsiari, A., Stangel, M., Fahlke, C. M., & Wiendl, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003149 · Cited by 85
Translational Control of Glial Glutamate Transporter EAAT2 Expression
Tian, G., Lai, L., Guo, H., Lin, Y., Butchbach, M. E. R., Chang, Y., & Lin, C. G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m609822200 · Cited by 85
Regulation of xCT expression and system $$ x_{\text{c}}^{ - } $$ function in neuronal cells
Lewerenz, J., Maher, P. A., & Methner, A. (2011) · Amino Acids · doi:10.1007/s00726-011-0862-x · Cited by 85
Minimal hepatic encephalopathy
Stewart, C. A., & Smith, G. E. (2007) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0999 · Cited by 84
Excitatory amino acid transporters as potential drug targets
Bunch, L., Erichsen, M. N., & Jensen, A. A. (2009) · Expert opinion on therapeutic targets · doi:10.1517/14728220902926127 · Cited by 91
Ceftriaxone-induced up-regulation of cortical and striatal GLT1 in the R6/2 model of Huntington's disease
Sari, Y., Prieto, A. L., Barton, S. J., Miller, B., & Rebec, G. V. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-62 · Cited by 84
Proline-Catalyzed Diastereoselective Direct Aldol Reaction between 4-Oxoazetidine-2-carbaldehydes and Ketones
Alcaide, B., Almendros, P., Luna, A., & Torres, M. R. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0604235 · Cited by 84
Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening: An Approach to Prevent Excitotoxicity
Colton, C. K., Kong, Q., Lai, L., Zhu, M. X., Seyb, K. I., Cuny, G. D., Xian, J., Glicksman, M. A., & Lin, C.-L. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110370998 · Cited by 86
Functional Maturation of Human Stem Cell-Derived Neurons in Long-Term Cultures
Lam, R. S., Töpfer, F. M., Wood, P. G., Busskamp, V., & Bamberg, E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169506 · Cited by 82
Beta-lactam antibiotics
Page, M. G. P. (2012) · Antibiotic Discovery and Development · doi:10.1007/978-1-4614-1400-1_3 · Cited by 84
Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation
Li, X., Semenova, S., D’Souza, M. S., Stoker, A. K., & Markou, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.042 · Cited by 87
Neuroprotective effect of ceftriaxone in a rat model of traumatic brain injury
Cui, C., Cui, Y., Gao, J., Sun, L., Wang, Y., Wang, R. C., Li, R., Tian, Y., Song, S., & Cui, J. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1585-4 · Cited by 83
Electroconvulsive seizure‐induced gene expression profile of the hippocampus dentate gyrus granule cell layer
Ploski, J. E., Newton, S. S., & Duman, R. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04156.x · Cited by 82
Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model
Maltecca, F., Baseggio, E., Consolato, F., Mazza, D., Podini, P., Young, S., Drago, I., Bahr, B. A., Puliti, A., Codazzi, F., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74770 · Cited by 82
Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex
Zeng, L., Bero, A. W., Zhang, B., Holtzman, D. M., & Wong, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.12.020 · Cited by 82
Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats
Qrunfleh, A. M., Alazizi, A., & Sari, Y. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113482529 · Cited by 80
Changes in the expression of the glutamate transporter EAAT3/EAAC1 in health and disease
Bianchi, M. G., Bardelli, D., Chiu, M., & Bussolati, O. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1484-0 · Cited by 81
Ceftriaxone Ameliorates Motor Deficits and Protects Dopaminergic Neurons in 6-Hydroxydopamine-Lesioned Rats
Leung, T. C. H., Lui, C. N. P., Chen, L. W., Yung, W. H., Chan, Y. S., & Yung, K. K. L. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200072h · Cited by 78
Recent progress in upconversion nanomaterials for emerging optical biological applications
Chen, H., Ding, B., Ma, P., & Lin, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114414 · Cited by 80
Identification of Small Molecule Lead Compounds for Visceral Leishmaniasis Using a Novel Ex Vivo Splenic Explant Model System
Osorio, E. Y., Travi, B. L., Renslo, A. R., Peniche, A. G., & Melby, P. C. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000962 · Cited by 79
Pharmacologic inhibition of Hsp90 to prevent GLT-1 degradation as an effective therapy for epilepsy
Sha, L., Wang, X., Li, J., Shi, X., Wu, L., Shen, Y., & Xu, Q. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160667 · Cited by 79
Post-translational Regulation of GLT-1 in Neurological Diseases and Its Potential as an Effective Therapeutic Target
Peterson, A. R., & Binder, D. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00164 · Cited by 82
Comprehensive Research on Past and Future Therapeutic Strategies Devoted to Treatment of Amyotrophic Lateral Sclerosis
Sever, B., Ciftci, H. I., DeMi̇rci̇, H., Sever, H., Ocak, F., Yuluğ, B., Tateishi, H., Tateishi, T., Otsuka, M., Fujita, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052400 · Cited by 80
Acute Regulation of Sodium-Dependent Glutamate Transporters: A Focus on Constitutive and Regulated Trafficking
Robinson, M. B. (2006) · Springer eBooks · doi:10.1007/3-540-29784-7_13 · Cited by 78
Astrocytes gate Hebbian synaptic plasticity in the striatum
Valtcheva, S., & Venance, L. (2016) · Nature Communications · doi:10.1038/ncomms13845 · Cited by 83
Therapeutic neuroprotective agents for amyotrophic lateral sclerosis
Pandya, R. S., Zhu, H., Li, W., Bowser, R. P., Friedlander, R. M., & Wang, X. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1415-0 · Cited by 77
Adenosine and Glutamate Signaling in Neuron–Glial Interactions: Implications in Alcoholism and Sleep Disorders
Nam, H. W., McIver, S. R., Hinton, D. J., Thakkar, M. M., Sari, Y., Parkinson, F. E., Haydon, P. G., & Choi, D. (2012) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01722.x · Cited by 77
Spirocyclic β-Lactams: Synthesis and Biological Evaluation of Novel Heterocycles
Bari, S. S., & Bhalla, A. (2010) · Topics in heterocyclic chemistry · doi:10.1007/7081_2009_8 · Cited by 75
The Rho kinase inhibitor Fasudil up‐regulates astrocytic glutamate transport subsequent to actin remodelling in murine cultured astrocytes
Lau, C., O'Shea, R., Broberg, B. V., Bischof, L., & Beart, P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01259.x · Cited by 75
Astrocytes: Emerging Therapeutic Targets in Neurological Disorders
Valori, C. F., Guidotti, G., Brambilla, L., & Rossi, D. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.04.010 · Cited by 77
Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment
Filipi, T., Heřmanová, Z., Turečková, J., Vaňátko, O., & Anděrová, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010261 · Cited by 76
Attenuation of Ethanol Withdrawal by Ceftriaxone-Induced Upregulation of Glutamate Transporter EAAT2
Abulseoud, O. A., Çamsarı, U. M., Ruby, C. L., Kasasbeh, A. S., Choi, S. H., & Choi, D. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.14 · Cited by 75
The upregulation of GLAST-1 is an indirect antiapoptotic mechanism of GDNF and neurturin in the adult CNS
Koeberle, P. D., & Bähr, M. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402281 · Cited by 74
Effect of sub-MIC concentrations of metronidazole, vancomycin, clindamycin and linezolid on toxin gene transcription and production in Clostridium difficile
Gerber, M., Walch, C., Löffler, B., Tischendorf, K., Reischl, U., & Ackermann, G. (2008) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47739-0 · Cited by 74
Multifaceted roles for astrocytes in spreading depolarization: A target for limiting spreading depolarization in acute brain injury?
Seidel, J. L., Escartin, C., Ayata, C., Bonvento, G., & Shuttleworth, C. W. (2015) · Glia · doi:10.1002/glia.22824 · Cited by 77
L‐type voltage‐operated calcium channels contribute to astrocyte activation In vitro
Cheli, V. T., Santiago González, D. A., Smith, J., Spreuer, V., Murphy, G. G., & Paez, P. M. (2016) · Glia · doi:10.1002/glia.23013 · Cited by 71
Neuron-specific deficits of bioenergetic processes in the dorsolateral prefrontal cortex in schizophrenia
Sullivan, C. R., Koene, R., Hasselfeld, K., O'Donovan, S. M., Ramsey, A. J., & McCullumsmith, R. E. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0035-3 · Cited by 73
Small Molecules in Development for the Treatment of Spinal Muscular Atrophy
Calder, A. N., Androphy, E. J., & Hodgetts, K. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00670 · Cited by 73
Rising Stars: Astrocytes as a Therapeutic Target for ALS Disease
Izrael, M., Slutsky, S. G., & Revel, M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00824 · Cited by 73
Ceftriaxone rescues hippocampal neurons from excitotoxicity and enhances memory retrieval in chronic hypobaric hypoxia
Hota, S. K., Barhwal, K. K., Ray, K., Singh, S. B., & Ilavazhagan, G. (2008) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.01.003 · Cited by 73
Intrathecal Delivery of Hepatocyte Growth Factor From Amyotrophic Lateral Sclerosis Onset Suppresses Disease Progression in Rat Amyotrophic Lateral Sclerosis Model
Ishigaki, A., Aoki, M., Nagai, M., Warita, H., Kato, S., Kato, M., Nakamura, T., Funakoshi, H., & Itoyama, Y. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318159886b · Cited by 73
Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS
Ghoddoussi, F., Galloway, M. P., Jambekar, A. A., Bame, M., Needleman, R. B., & Brusilow, W. S. A. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.11.013 · Cited by 73
Chronic ceftriaxone treatment rescues hippocampal memory deficit in AQP4 knockout mice via activation of GLT-1
Yang, J., Li, M., Luo, Y., Chen, T., Liu, J., Fang, P., Jiang, B., Hu, Z., Jin, Y., Chen, J., et al. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.08.009 · Cited by 73
Contrasting the Role of xCT and GLT-1 Upregulation in the Ability of Ceftriaxone to Attenuate the Cue-Induced Reinstatement of Cocaine Seeking and Normalize AMPA Receptor Subunit Expression
LaCrosse, A., O'Donovan, S. M., Sepulveda-Orengo, M. T., McCullumsmith, R. E., Reissner, K. J., Schwendt, M., & Knackstedt, L. A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3717-16.2017 · Cited by 76
Rescue of glutamate transport in the lateral habenula alleviates depression- and anxiety-like behaviors in ethanol-withdrawn rats
Kang, S., Li, J., Bekker, A., & Ye, J.-H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.013 · Cited by 75
Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
Yimer, E. M., Hishe, H. Z., & Tuem, K. B. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00236 · Cited by 72
Glutamate transport: a new bench to bedside mechanism for treating drug abuse
Spencer, S., & Kalivas, P. W. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx050 · Cited by 71
Stem Cell Technology for the Study and Treatment of Motor Neuron Diseases
Lunn, J. S., Sakowski, S. A., Federici, T., Glass, J. D., Boulis, N. M., & Feldman, E. L. (2011) · Regenerative Medicine · doi:10.2217/rme.11.6 · Cited by 72
Corticostriatal Dysfunction in Huntington’s Disease: The Basics
Bunner, K. D., & Rebec, G. V. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00317 · Cited by 70
Structure-Function Relationship of Transporters in the Glutamate–Glutamine Cycle of the Central Nervous System
Hayashi, M. K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041177 · Cited by 76
Ariadne's ChemEffect and Pathway Studio knowledge base
Yuryev, A., Kotelnikova, E. A., & Daraselia, N. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903413488 · Cited by 72
Colonic bacterial translocation as a possible factor in stress-worsening experimental stroke outcome
Caso, J. R., Hurtado, O., Pereira, M. P., García‐Bueno, B., Menchen, L. A., Alou, L., Gómez-Lus, M. L., Moro, M. Á., Lizasoaín, I., & Leza, J. C. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90825.2008 · Cited by 72
Recent advances in motor neuron disease
Damme, P. V., & Robberecht, W. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832ffbe3 · Cited by 76
Potentiating SLC transporter activity: Emerging drug discovery opportunities
Rives, M., Javitch, J. A., & Wickenden, A. D. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.010 · Cited by 72
Identification of Novel Allosteric Modulators of Glutamate Transporter EAAT2
Kortagere, S., Mortensen, O. V., Xia, J., Lester, W. C., Fang, Y., Srikanth, Y. V. V., Salvino, J. M., & Fontana, A. C. K. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00308 · Cited by 72
Ceftriaxone Blocks the Polymerization of α-Synuclein and Exerts Neuroprotective Effects in Vitro
Ruzza, P., Siligardi, G., Hussain, R., Marchiani, A., Islami, M., Bubacco, L., Delogu, G., Fabbri, D., Dettori, M. A., Sechi, M., et al. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn400149k · Cited by 70
Spinal muscular atrophy: An update on therapeutic progress
Seo, J., Howell, M. D., Singh, N. N., & Singh, R. N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.005 · Cited by 71
Induction of Inflammatory Cytokines by a Keratin Mutation and their Repression by a Small Molecule in a Mouse Model for EBS
Lu, H., Chen, J., Planko, L., Zigrino, P., Klein‐Hitpaß, L., & Magin, T. M. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700918 · Cited by 71
The Role of Excitatory Amino Acid Transporters in Cerebral Ischemia
Chao, X., Fei, F., & Fei, Z. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0178-3 · Cited by 74
Astrocytes as Key Regulators of Neural Signaling in Health and Disease
Won, W., Bhalla, M., Lee, J., & Lee, C. J. (2025) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-112723-035356 · Cited by 76
Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening
Moorwood, C., Lozynska, O., Suri, N., Napper, A. D., Diamond, S. L., & Khurana, T. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026169 · Cited by 71
Molecular changes evoked by the beta-lactam antibiotic ceftriaxone across rodent models of substance use disorder and neurological disease
Smaga, I., Fierro, D., Mesa, J., Filip, M., & Knackstedt, L. A. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.016 · Cited by 69
Evidence against Cellular Internalization in Vivo of NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica
Ratelade, J., Bennett, J. L., & Verkman, A. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297275 · Cited by 69
COMPUTATIONAL APPROACHES FOR DRUG REPOSITIONING AND COMBINATION THERAPY DESIGN
Kotelnikova, E. A., Yuryev, A., Mazo, I. A., & Daraselia, N. (2010) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720010004732 · Cited by 69
Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation
Rawls, S. M., Zielinski, M. A., Patel, H., Sacavage, S., Baron, D. A., & Patel, D. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.10.010 · Cited by 69
Protecting the retinal neurons from glaucoma: Lowering ocular pressure is not enough
Pascale, A., Drago, F., & Govoni, S. M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.002 · Cited by 70
REVIEW ARTILCE: Cell therapy and stem cells in animal models of motor neuron disorders
Hedlund, E., Hefferan, M. P., Maršala, M., & Ole Isacson, A. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05780.x · Cited by 69
Neuronal activity mediated regulation of glutamate transporter GLT‐1 surface diffusion in rat astrocytes in dissociated and slice cultures
Awabdh, S. A., Gupta, S., Sheehan, D. F., Muir, J., Norkett, R., Twelvetrees, A. E., Griffin, L. D., & Kittler, J. T. (2016) · Glia · doi:10.1002/glia.22997 · Cited by 68
New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
FTD and ALS—translating mouse studies into clinical trials
Ittner, L. M., Halliday, G. M., Kril, J. J., Götz, J., Hodges, J. R., & Kiernan, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.65 · Cited by 70
Exciting Complexity: The Role of Motor Circuit Elements in ALS Pathophysiology
Gunes, Z. I., Kan, V. W. Y., Ye, X., & Liebscher, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00573 · Cited by 74
Effects of Ceftriaxone on the Behavioral and Neuronal Changes in an MPTP-Induced Parkinson’s Disease Rat Model
Ho, S.-C., Hsu, C.-C., Pawlak, C. R., Tikhonova, M. A., Lai, T.-J., Amstislavskaya, T. G., & Ho, Y.-J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.022 · Cited by 65
AEG-1/MTDH/LYRIC, the Beginning
Lee, S., Kang, D., DeSalle, R., Sarkar, D., & Fisher, P. B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-401676-7.00001-2 · Cited by 67
Self-citation
Glutamate Transporter 1: Target for the Treatment of Alcohol Dependence
Rao, S., & Sari, Y. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803530511 · Cited by 69
Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats
Alhaddad, H., Kim, N. T., Aal-Aaboda, M. S., Althobaiti, Y. S., Leighton, J. L., Boddu, S. H. S., Wei, Y., & Sari, Y. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00366 · Cited by 66
Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice
Alajaji, M., Bowers, M. S., Knackstedt, L. A., & Damaj, M. I. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3047-3 · Cited by 66
The Glial Glutamate Transporter 1 (GLT1) Is Expressed by Pancreatic β-Cells and Prevents Glutamate-induced β-Cell Death
Cairano, E. S. D., Davalli, A. M., Perego, L., Sala, S., Sacchi, V. F., Rosa, S. L., Finzi, G., Placidi, C., Capella, C., Conti, P., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.183517 · Cited by 66

Authors: Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., Toan, S. V., Bruijn, L. I., Su, Z.-Z., Gupta, P., & Fisher, P. B.
Affiliations: Johns Hopkins University (US)
Amyotrophic Lateral Sclerosis Association (US)
Columbia University Irving Medical Center (US)
Corresponding author: Rothstein, Jeffrey D.
ORCID: Rothstein, Jeffrey D.
Huang, Yanhua H.
Bergles, Dwight E.
Gupta, Pankaj
Fisher, Paul B.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2005-01
Volume: 433
Issue: 7021
Pages: 73-77
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature03180
OpenAlex: W2083204774
Cited by: 1,518
References: 27
Citations by year: 2026: 49 · 2025: 52 · 2024: 47 · 2023: 48 · 2022: 53 · 2021: 55 · 2020: 60 · 2019: 56 · 2018: 52 · 2017: 76 · 2016: 85 · 2015: 84 · 2014: 107 · 2013: 96 · 2012: 98
FWCI: 31.20
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Muscular Dystrophy Association
Johns Hopkins University
Robert Packard Center for ALS Research, Johns Hopkins University
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: beta-lactam antibiotics, ceftriaxone, penicillin, GLT-1, glutamate transporters, neuroprotection, glutamate excitotoxicity, amyotrophic lateral sclerosis, ischemic brain injury, motor neuron degeneration, drug repurposing, transcriptional activation, astrocytes
MeSH terms: Animals, Anti-Bacterial Agents, Ceftriaxone, Cell Count, Cells, Cultured, Central Nervous System, Drug Evaluation, Preclinical, Gene Expression Regulation, Mice, Transgenic, Motor Neurons, Penicillins, Promoter Regions, Genetic, RNA, Messenger, United States, United States Food and Drug Administration, Transcriptional Activation, Genes, Reporter, Neuroprotective Agents, Ischemic Preconditioning, Excitatory Amino Acid Transporter 2, beta-Lactams, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks